Cardiovascular Disease
Cardiovascular disease (CVD) is a broad term encompassing various diseases of the heart and blood vessels, including coronary artery disease, heart failure, hypertensive heart disease, and more. Atherosclerotic CVD (ASCVD), the most common subtype, often leads to strokes and heart attacks.
Health Outcomes
- Altered Circulating Metabolic Profile
- Altered Fatty Acid Profiles
- Change in Waist-to-Hip Ratio
- Changed Leukocyte Telomere Length
- Changed Plasma Glycerophospholipid Levels
- Controlled Serum Cholesterol Levels
- Decreased Uncarboxylated to Total Osteocalcin Ratio
- Delayed Cardiac Pathology
- Developed Endocarditis
- Disease Prevention
- Elevated Malondialdehyde Levels
- Elevated Plasma-Branched Chain Amino Acids
- Elevated Redox Status
- Elevated Serum Leptin Levels
- Elevated Serum Lipoprotein Lipase Levels in Gilts
- Elevated Triglyceride Levels
- Enhanced AMPK Activation
- Enhanced Antioxidant Bioaccessibility
- Enhanced Antioxidant Capacity
- Enhanced Health Promotion
- Enhanced Reactive Oxygen Species Resistance
- Enhanced Reverse Cholesterol Transport
- Identified ACE-Inhibitory Peptides
- Improved 5000 m Running Time
- Improved Aerobic Capacity
- Improved Aerobic Power
- Improved Aerobic Stability
- Improved Antihypertensive Activity
- Improved Antioxidant Activity
- Improved Atherosclerosis-Related Cardiovascular Risk Markers
- Improved Bioactivity
- Improved Blood Biochemical Indicators
- Improved Blood Lipid Profile
- Improved Cardiometabolic Health
- Improved Cardioprotective Activity
- Improved Cardiovascular Disease Marker
- Improved Cardiovascular Function
- Improved Cardiovascular Health
- Improved Cholesterol Levels
- Improved Cholesterol Metabolism
- Improved Cholesterol Profile
- Improved Cycling Time Trial Performance
- Improved Dyslipidemia
- Improved Endothelial Reactivity
- Improved Endothelium-Dependent Vasodilation in Resistance Arteries
- Improved Estimated VO2max
- Improved Event-Free Survival
- Improved Exercise Function
- Improved Exercise Performance
- Improved Exercise Stress Test Grade
- Improved Fatty Acid Composition
- Improved Fibrinolytic Activity
- Improved Fish Chemical Composition
- Improved Fitness in Breastfed Infants
- Improved Flow-Mediated Dilation
- Improved Flow-Mediated Vasodilation
- Improved Folate Levels
- Improved Glutathione Level
- Improved Glutathione Redox Ratio
- Improved Glycerophospholipid Metabolism
- Improved Health in Elderly Populations
- Improved Heart Rate Recovery
- Improved Heart Rate Variability
- Improved High-Intensity Intermittent Exercise Performance
- Improved Homeostasis
- Improved LDL-C to HDL-C Ratio
- Improved Lactate Threshold
- Improved Left Ventricular Ejection Fraction
- Improved Lifespan
- Improved Lipid Metabolism
- Improved Lipid Profile
- Improved Lipid Serum Homeostasis
- Improved Longevity
- Improved Low-Density Lipoprotein Composition
- Improved Maximal Oxygen Capacity
- Improved Mean Arterial Pressure
- Improved Metabolic Syndrome Biomarkers
- Improved Monocyte Activation
- Improved Myocardial Strain Rate
- Improved Obesity Parameters
- Improved Overall Health
- Improved Overall Health Status
- Improved Oxidative Metabolism Regulation
- Improved Oxidative Status
- Improved Oxidative Stress Biomarker
- Improved Oxidative Stress Marker
- Improved Plasma Antioxidant Levels
- Improved Plasma Cholesterol Clearance
- Improved Plasma Lipid Levels
- Improved Prognosis of Type 2 Diabetes Mellitus
- Improved Proportion of Healthy Days
- Improved Reactive Hyperemia Index
- Improved Redox Homeostasis
- Improved Retinal Vascular Health
- Improved Run Time
- Improved Serum Averages
- Improved Serum Biochemistry
- Improved Serum Lipids
- Improved Serum Parameters
- Improved Serum SOD Activity
- Improved Stress-Strain Index
- Improved Superoxide Dismutase Activity
- Improved Superoxide Dismutase Level
- Improved Survival at 24 Months
- Improved Swimming Performance
- Improved Systemic Health
- Improved Total Antioxidant Capacity
- Improved Total Antioxidative Status
- Improved Total Cholesterol Levels
- Improved Triglyceride Levels
- Improved VO2 Max
- Improved VO2max
- Improved Vascular Endothelial Function
- Improved Vitamin D Levels
- Improved Waist-to-Hip Ratio
- Improved Weight Control
- Improved Yo-Yo Test Performance
- Improved n-6 to n-3 PUFA Ratio
- Increased AMPK Activation
- Increased Adiponectin Levels
- Increased Antioxidant Potential
- Increased Apolipoprotein A-V Levels
- Increased Beneficial Gut Bacteria
- Increased Bioactivity
- Increased Bioavailability of Phenolics
- Increased Body Weight
- Increased Bone Marrow Myelopoiesis
- Increased Branched Chain Amino Acid Levels
- Increased C-Reactive Protein Level
- Increased CD68 to CD163 Ratio
- Increased Catalase Activity
- Increased Circulating Vitamin K2 Levels
- Increased Complement C3 Level
- Increased Conjugated Linoleic Acid Production
- Increased Cysteine Level
- Increased Endogenous Acrolein Formation
- Increased Endurance Swimming Time
- Increased Exercise Endurance
- Increased FNDC5 Concentration
- Increased Ferric Reducing Ability of Plasma
- Increased Folate Bioavailability
- Increased GSH/GSSG Ratio
- Increased General Morbidity
- Increased Glutathione Level
- Increased Glutathione Peroxidase Activity
- Increased Glutathione Peroxidase Level
- Increased HDL Cholesterol Levels
- Increased High-Density Lipoprotein Cholesterol
- Increased Homocysteine Level
- Increased Hormone-Sensitive Lipase Activity
- Increased Inhibition of Lipid Oxidation
- Increased KLF4 Protein Levels
- Increased LDL Cholesterol Level
- Increased Leptin Level
- Increased Leptin Levels
- Increased Menaquinone-7 Levels
- Increased Mortality
- Increased Myeloperoxidase Activity
- Increased Nitric Oxide Bioavailability
- Increased Osteoprotegerin Immunostaining
- Increased Oxidative Stress
- Increased Paraoxonase 1 Enzyme Activity
- Increased Physical Activity
- Increased Plasma ApoA-V Levels
- Increased Plasma Omega-3 Fatty Acids
- Increased Plasma Vitamin K Levels
- Increased Polyphenol Level
- Increased Polyunsaturated Fatty Acids in Breast Meat
- Increased Polyunsaturated Fatty Acids in Milk
- Increased Pro-inflammatory Cytokine IL-6
- Increased Production of ACE-Inhibitory Peptides
- Increased Production of Bioactive Peptides
- Increased Production of Bioactive Peptides with Angiotensin Converting Enzyme Inhibitory Activity
- Increased Reactive Oxygen Species Response
- Increased Serum Amyloid Protein
- Increased Serum High-Molecular Weight Adiponectin
- Increased Serum NAD+ Levels
- Increased Serum Triglycerides
- Increased Systolic Blood Pressure
- Increased Total Thiol Level
- Increased Triglyceride Level
- Increased Viable Cell Antioxidant Activity
- Increased Visceral Fat Mass
- Induction of Browning of White Adipose Tissue
- Inhibited Lipid Oxidation
- Maintained High-Density Lipoprotein Levels
- Mitigated Cardiac Injury from Myocardial Infarction
- Modified Serum Metabolomic Pathways
- Modulated PPAR/SREBP Pathway
- Multiple Health-Promoting Effects
- No Adverse Health Effects
- No Change in Major Cardiovascular Event
- No Improvement in Total Cholesterol
- No Reduction in Meat Cholesterol Levels
- No Significant Change in Total Cholesterol
- No Significant Effect on C-Reactive Protein Levels
- Normalized Lipid Metabolism
- Prevented Increase in Serum CML Levels
- Prevention of Hypercholesterolemia
- Prolonged Cardiac Allograft Survival
- Prolonged Survival Periods with Antiphospholipid Syndrome
- Reduced Abdominal Visceral Fat
- Reduced Acute Kidney Injury
- Reduced Advanced Glycation End Product Level
- Reduced All-Cause Mortality
- Reduced Angiotensin I-Converting Enzyme Activity
- Reduced Aortic Inflammation
- Reduced Aortic Superoxide Levels
- Reduced Aortic Thickness
- Reduced Apelin Gene Expression
- Reduced Apolipoprotein B Levels
- Reduced Apolipoprotein B to A-1 Ratio
- Reduced Apolipoprotein B-100
- Reduced Apolipoprotein B-100 to Apolipoprotein A-1 Ratio
- Reduced Arterial Calcifying Lesion Development
- Reduced Arterial Stiffness
- Reduced Atherogenic Index
- Reduced Atherosclerosis Risk Factors
- Reduced Atherosclerotic Cardiovascular Disease Event
- Reduced Atherosclerotic Plaque Formation
- Reduced Atrial Fibrillation Risk
- Reduced Augmentation Index
- Reduced Blood Lipid Levels
- Reduced Blood Pressure in Offspring
- Reduced Blood Serum Cholesterol
- Reduced Body Fat
- Reduced C-Reactive Protein Level
- Reduced C-Reactive Protein Levels
- Reduced Carboxymethyl Lysine
- Reduced Cardiac Injury
- Reduced Cardiovascular Event
- Reduced Catalase Activity
- Reduced Cause-Specific Mortality
- Reduced Cellular Senescence
- Reduced Central Blood Pressure
- Reduced Cerebrovascular Mortality
- Reduced Cholesterol Metabolism
- Reduced Conicity Index
- Reduced Dephosphorylated-Uncarboxylated Matrix Gla Protein Level
- Reduced Dietary Advanced Glycation End Product Intake
- Reduced Dyslipidemia Parameters
- Reduced Dyslipidemia in Metabolic Syndrome
- Reduced Exhaustion During Stress Test
- Reduced Fasting Insulin Level
- Reduced Ferroptosis
- Reduced Flavonifractor Abundance
- Reduced Flavonoid Levels
- Reduced Folic Acid Level
- Reduced Glutathione Loss
- Reduced Glycation End Product Accumulation
- Reduced Glycative Stress Marker Level
- Reduced HDL Cholesterol Level
- Reduced HIF-1α Level
- Reduced HMG-CoA Reductase Inhibition
- Reduced Harmful Lipid Levels
- Reduced Heart Rate Variability
- Reduced Heat Stress
- Reduced High-Density Lipoprotein Cholesterol Level
- Reduced High-Sensitivity C-Reactive Protein Level
- Reduced Homocysteine Level
- Reduced Hydroperoxide Levels
- Reduced Hypercholesterolemia
- Reduced Hypercholesterolemia Incidence
- Reduced Hyperlipidemia Symptoms
- Reduced ICAM-1 Level
- Reduced Insulin Sensitivity
- Reduced Insulin/IGF-1 Signaling
- Reduced LDL Cholesterol
- Reduced LDL Levels
- Reduced LDL Oxidation
- Reduced Lead Bioaccumulation
- Reduced Lipid Levels
- Reduced Lipid Oxidation
- Reduced Lipid Peroxidation
- Reduced Lipid Profiles
- Reduced Low-Density Lipoprotein Cholesterol
- Reduced Lysophosphatidylcholine Level
- Reduced Lysophosphatidylethanolamine 18:1 Level
- Reduced Malondialdehyde Generation
- Reduced Malondialdehyde Level
- Reduced Mean Blood Pressure
- Reduced Metabolic Inflammation
- Reduced Metabolic Lipopolysaccharide-Related Inflammation
- Reduced Monocyte Adhesion
- Reduced Monocyte Chemoattractant Protein-1 Level
- Reduced Morbidity
- Reduced Morbidity Rate
- Reduced Mortality
- Reduced Mortality Rate
- Reduced Mortality from Frailty
- Reduced Myeloperoxidase Activity
- Reduced Myocardial Infarct Size
- Reduced Myocardial Injury
- Reduced NADPH Oxidase Activity
- Reduced Non-Communicable Disease Risk
- Reduced Non-High-Density Lipoprotein Cholesterol
- Reduced Nuclear Factor Kappa-B Level
- Reduced Obesity-Related Microbial Taxa
- Reduced Obesity-Related Taxa
- Reduced Oxidative Stress
- Reduced Oxidative Stress Index
- Reduced Oxidative Stress Marker
- Reduced Oxidative Stress Marker Level
- Reduced Oxidative Tissue Injury
- Reduced Oxidized Low-Density Lipoprotein Level
- Reduced Plant Sterols
- Reduced Plaque
- Reduced Plasma CRP Levels
- Reduced Plasma Cholesterol Levels
- Reduced Plasma Homocysteine Levels
- Reduced Post-Exercise Serum Amyloid A Increase
- Reduced Postprandial Glycemic Response
- Reduced Postprandial Triacylglycerol Response
- Reduced Pre-eclampsia
- Reduced Proinflammatory Signaling
- Reduced Protein Oxidation
- Reduced Reactive Oxygen Species Formation
- Reduced Risk of COVID-19 Progression
- Reduced SCD1 Activity
- Reduced Saturated Fatty Acids in Breast Meat
- Reduced Senescence-Associated Secretory Phenotype
- Reduced Serious Adverse Events
- Reduced Serum 8-isoprostane Concentrations
- Reduced Serum Carboxymethyl-Lysine Levels
- Reduced Serum Cholesterol Levels
- Reduced Serum Glycerophospholipid Levels
- Reduced Serum Inflammatory Cytokines
- Reduced Serum LDL Levels
- Reduced Serum Lipid Levels
- Reduced Serum Plasminogen Activator Inhibitor-1
- Reduced Serum Total Cholesterol Levels
- Reduced Serum Triglycerides
- Reduced Soluble Receptor of Advanced Glycation End Product Level
- Reduced Sugar-Sweetened Beverage Intake
- Reduced Symptoms Associated with High-Fat Diet
- Reduced TBARS Levels
- Reduced TMAO Level
- Reduced Thrombosis
- Reduced Total Blood Cholesterol
- Reduced Total Cholesterol
- Reduced Total Cholesterol Levels
- Reduced Triglyceride Levels
- Reduced Triglycerides
- Reduced Trimethylamine N-oxide Levels
- Reduced Trypanosoma cruzi Parasitaemia
- Reduced Type 2 Diabetes Symptoms
- Reduced VLDL Cholesterol Level
- Reduced Vascular Damage
- Reduced Vascular Stiffness
- Reduced Very Low-Density Lipoprotein
- Reduced Visceral Fat
- Reduced Visceral Fat Accumulation
- Reduced Visceral Fat Mass
- Reduced Visfatin Level
- Reduced Waist Circumference
- Reduced Waist-to-Height Ratio
- Reduced Yolk Cholesterol Content
- Reduced hsCRP Level
- Regulated Blood Lipid Levels
- Regulated Lipid Metabolism
- Restored HDL Levels
- Restored Lipid Metabolism
- Safe Administration
- Stabilized Cell Membranes
- Stabilized Plasma Cholesterol Levels
- Stabilized Visceral Fat Area
- Stable High-Density Lipoprotein Cholesterol Level
- Supported Physiological Function in Elderly
- Suppressed PPAR/SREBP Pathway Gene Activity
- Unchanged Plasma Lipid Levels